Home Business Trump’s Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundup
Trump’s Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundup


El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when prescribed to treat sleep apnea. The cost of prescription drugs is set to climb in 2025 and beyond, according to a report from the investment bank TD Cowen. And President-elect Donald Trump’s…
Author Of article : Bruce Gil
The cities with the best money management skills, according to WalletHub
Residents in these cities have high credit scores, low income-to-debt ratios, and rarely m…






